About Resplice
Resplice is a company based in Hyderabad (India) founded in 2022. It operates as a B2B. The company has 1 employees as of March 31, 2023. Resplice offers products and services including Gut Symbiont Restoration Therapy. Resplice operates in a competitive market with competitors including Clario, Lightship, SFJ Pharmaceuticals, N-Power Medicine and Cognivia, among others.
- Headquarter Hyderabad, India
- Employees 1 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Providence Microbiome Research Center Private Limited
- Date of Incorporation 11 Sep, 2020
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$174.17 K (USD)0as on Mar 31, 2023
-
Net Profit
-$1.09 K (USD)-354.76as on Mar 31, 2023
-
EBITDA
-$1.09 K (USD)-354.76as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Resplice
Resplice offers a comprehensive portfolio of products and services, including Gut Symbiont Restoration Therapy.
Uses faecal microbiota transfer to address autism symptoms
Funding Insights of Resplice
Detailed funding history for Resplice
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Resplice
Investment portfolio details for Resplice
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Resplice
Detailed financials for Resplice
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Resplice Comparisons
Peer comparison for Resplice
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Resplice
Resplice operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Clario, Lightship, SFJ Pharmaceuticals, N-Power Medicine and Cognivia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CRO focused on providing clinical trial supply services for biopharma sector
|
|
| Locked | Locked | Locked |
Direct-to-patient clinical trial solutions are provided by Lightship.
|
|
| Locked | Locked | Locked |
Specialty pharmaceutical company based on partnering model
|
|
| Locked | Locked | Locked |
Clinical trial services are provided to support medical research initiatives.
|
|
| Locked | Locked | Locked |
Provider of data modeling and patient insights for clinical trial optimization
|
|
| Locked | Locked | Locked |
Clinical trial imaging workflow and data management technology is provided.
|
Detailed competitors of Resplice
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Resplice
Complete news archive for Resplice
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Resplice
Resplice was founded in 2022.
Resplice is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2023, the latest employee count at Resplice is 1.
Annual revenue of Resplice is $174.17K as on Mar 31, 2023.
GSRT focuses on developing gut symbiont restoration therapy to treat autism spectrum disorders through faecal microbiota transfer. Based in Hyderabad, India, they run academic clinical trials at St. Theresa Hospital, assessing gut microbiome and epigenetic changes. Collaborations with institutions like CDFD support studies on autisms causes and potential prevention. The initiative aims to explore gene-environment interactions and improve therapeutic outcomes.
Resplice's top competitors include Lightship, SFJ Pharmaceuticals and N-Power Medicine.
Resplice offers Gut Symbiont Restoration Therapy.